SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rubble who wrote (2809)7/22/1997 11:32:00 PM
From: Frostman   of 3991
 
Remember Dick and Jane?

R-Man,
Absolutely everything you are saying makes sense. Maybe the 5% that read this thread control 90% of the stock.... et tu Rubble? There seems to be nothing wrong with this picture; we have a quality stock here that's in between spates of good news. Let's see, the UK announcement is up next, maybe 10 days out tops. Three weeks from now, I hope Richard will be working up 3rd quarter estimates based on full production.
Let's not forget that there is roughly a $0.04 per share milestone
payment that was delayed till Q3, and that First Boston's current
target price was just moved to $35 per share. The doubling of earnings estimates from Q1 has not even been answered by a full round of revisions. Personally, I believe in a few years, Muse will be sold over the counter and the target group will be simply: MEN. Not just
E.D. patients. (sorry Tunica)

But, I'm beginning to believe something is wrong with this picture.
I'm not going to get into manipulation theory, or planted press
releases, etc. I'm honestly not smart enough. The couple of times
in the last month or so I thought we were off to the races, though,
it just didn't happen. There were just more fellas voting against than for. But, betting against a constant flow of good news and responsible growth makes less sense every day. Shorting into q3 earnings for example probably won't make any sense at all.

In the mean time, in the space between good news stories, and before we get used to solid earnings... I've bought VVUS at 25 before, I'd be happy to do it again.

Remember the Dick and Jane stories?
Some things are Jane things, and some things
are Dick things. VVUS is a Dick thing. See Dick run.

Waxing irreverent,

Frostman
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext